An article in this week's edition of TIME magazine noted that more than 100,000 Americans, including celebrities such as Oprah Winfrey and Spike Lee, have taken genealogical DNA tests offered by commercial laboratories to learn more about their family history.

TIME told the story of Brent Kennedy of Wise, Va., who thought that he was of English and Scotch-Irish descent, even though he felt that members of his family looked more Arabic than English. After taking DNAPrint's EUROWITNESS 1.0(TM) test, Mr. Wise learned that he was 45% Northern and Western European, 25% Middle Eastern, 25% Turkish-Green and 5% South Asian.

The article can be accessed online at the magazine's website at http://www.time.com/time/magazine/article/0,9171,1079508,00.html .

An article published in the June 25 edition of The Globe and Mail (http://www.theglobeandmail.com ), a leading Toronto newspaper, reported how DNAPrint's DNAWITNESS(TM) forensics technology can be utilized to narrow the search for crime suspects.

DNAWITNESS is the only testing method available for drawing information about physical appearance from crime-scene DNA. The post-human genome technology uses genetic features called Ancestry Informative Markers to infer genomic ancesry admixture for individuals. The DNAWITNESS 2.5 and ANCESTRYbyDNA 2.5 assays measure the relative proportion of European, Sub- Saharan African, East Asian and Native American ancestry while the EURODNA 1.0 technology measures the relative proportion of Northern European, Southeastern European, Middle Eastern and South Asian sub-ancestry for individuals primarily of European descent. DNAWITNESS 2.5 is marketed only to law enforcement agencies. The Company developed and markets ANCESTRYbyDNA for the consumer market and individuals who are interested in learning their family heritage.

About DNAPrint genomics, Inc.

DNAPrint genomics, Inc. (http://www.dnaprint.com ) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests.

Forward-Looking Statements

All statements in this press release that are not historical are forward- looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.

     Company Contact:
     Richard Gabriel
     President and CEO
     941-366-3400

     -or-

     Ron Stabiner
     The Wall Street Group, Inc.
     212-888-4848